Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Aryl hydrocarbon receptor control of a disease tolerance defence pathway.

Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, Bicciato S, Mazza EM, Macchiarulo A, Vacca C, Iannitti R, Tissi L, Volpi C, Belladonna ML, Orabona C, Bianchi R, Lanz TV, Platten M, Della Fazia MA, Piobbico D, Zelante T, Funakoshi H, Nakamura T, Gilot D, Denison MS, Guillemin GJ, DuHadaway JB, Prendergast GC, Metz R, Geffard M, Boon L, Pirro M, Iorio A, Veyret B, Romani L, Grohmann U, Fallarino F, Puccetti P.

Nature. 2014 Jul 10;511(7508):184-90. doi: 10.1038/nature13323.

2.

Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis.

Puliti M, Momi S, Falcinelli E, Gresele P, Bistoni F, Tissi L.

Arthritis Rheum. 2012 Apr;64(4):1089-97. doi: 10.1002/art.33450. Epub 2011 Oct 31.

3.

Lack of B7-1 and B7-2 costimulatory molecules modulates the severity of group B Streptococcus-induced arthritis.

Puliti M, Bistoni F, Tissi L.

Microbes Infect. 2010 Apr;12(4):302-8. doi: 10.1016/j.micinf.2010.01.006. Epub 2010 Jan 28.

PMID:
20114085
4.

IL-4 deficiency decreases mortality but increases severity of arthritis in experimental group B Streptococcus infection.

Tissi L, Bistoni F, Puliti M.

Mediators Inflamm. 2009;2009:394021. doi: 10.1155/2009/394021. Epub 2009 Jul 7.

5.

Toll-like receptor 2 deficiency is associated with enhanced severity of group B streptococcal disease.

Puliti M, Uematsu S, Akira S, Bistoni F, Tissi L.

Infect Immun. 2009 Apr;77(4):1524-31. doi: 10.1128/IAI.00965-08. Epub 2009 Jan 29.

6.

Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity.

Jiang SM, Ishmael N, Dunning Hotopp J, Puliti M, Tissi L, Kumar N, Cieslewicz MJ, Tettelin H, Wessels MR.

J Bacteriol. 2008 Mar;190(6):1956-65. doi: 10.1128/JB.01677-07. Epub 2008 Jan 18.

7.

Exacerbation of group B streptococcal sepsis and arthritis in diabetic mice.

Puliti M, Bistoni F, Orefici G, Tissi L.

Microbes Infect. 2006 Aug;8(9-10):2376-83. Epub 2006 Jun 30.

PMID:
16844399
8.

Experimental model of infection with non-toxigenic strains of Corynebacterium diphtheriae and development of septic arthritis.

Puliti M, von Hunolstein C, Marangi M, Bistoni F, Tissi L.

J Med Microbiol. 2006 Feb;55(Pt 2):229-35.

PMID:
16434717
9.

Glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, inhibits the progression of group B streptococcal arthritis.

Tissi L, Puliti M, Bistoni F, Mosci P, Kozel TR, Vecchiarelli A.

Infect Immun. 2004 Nov;72(11):6367-72.

10.

Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense.

Liu GY, Doran KS, Lawrence T, Turkson N, Puliti M, Tissi L, Nizet V.

Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14491-6. Epub 2004 Sep 20.

11.

Inhibition of nitric oxide synthase exacerbates group B streptococcus sepsis and arthritis in mice.

Puliti M, von Hunolstein C, Bistoni F, Orefici G, Tissi L.

Infect Immun. 2004 Aug;72(8):4891-4.

12.

Role of interleukin-18 in experimental group B streptococcal arthritis.

Tissi L, McRae B, Ghayur T, von Hunolstein C, Orefici G, Bistoni F, Puliti M.

Arthritis Rheum. 2004 Jun;50(6):2005-13.

13.

Role of macrophages in experimental group B streptococcal arthritis.

Puliti M, von Hunolstein C, Bistoni F, Castronari R, Orefici G, Tissi L.

Cell Microbiol. 2002 Oct;4(10):691-700.

PMID:
12366405
14.

Regulatory role of interleukin-10 in experimental group B streptococcal arthritis.

Puliti M, Von Hunolstein C, Verwaerde C, Bistoni F, Orefici G, Tissi L.

Infect Immun. 2002 Jun;70(6):2862-8.

15.

The beneficial effect of interleukin-12 on arthritis induced by group B streptococci is mediated by interferon-gamma and interleukin-10 production.

Puliti M, von Hunolstein C, Bistoni F, Mosci P, Orefici G, Tissi L.

Arthritis Rheum. 2002 Mar;46(3):806-17.

16.

Influence of interferon-gamma administration on the severity of experimental group B streptococcal arthritis.

Puliti M, von Hunolstein C, Bistoni F, Mosci P, Orefici G, Tissi L.

Arthritis Rheum. 2000 Dec;43(12):2678-86.

17.

Severity of group B streptococcal arthritis in selected strains of laboratory mice.

Puliti M, Bistoni F, von Hunolstein C, Orefici G, Tissi L.

Infect Immun. 2001 Jan;69(1):551-5.

18.

Severity of group B streptococcal arthritis is correlated with beta-hemolysin expression.

Puliti M, Nizet V, von Hunolstein C, Bistoni F, Mosci P, Orefici G, Tissi L.

J Infect Dis. 2000 Sep;182(3):824-32. Epub 2000 Aug 17.

PMID:
10950777
19.

Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide.

von Hunolstein C, Parisi L, Tissi L, Recchia S, Alfarone G, Nicolini L, Volpe C, Wagner B, MotlovĂ  J, Orefici G.

J Med Microbiol. 1999 Nov;48(11):983-90.

PMID:
10535641
20.

Role of tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 in a mouse model of group B streptococcal arthritis.

Tissi L, Puliti M, Barluzzi R, Orefici G, von Hunolstein C, Bistoni F.

Infect Immun. 1999 Sep;67(9):4545-50.

21.

Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis.

Tissi L, von Hunolstein C, Bistoni F, Marangi M, Parisi L, Orefici G.

J Med Microbiol. 1998 Aug;47(8):717-23.

PMID:
9877193
22.

Carriage of group B Streptococcus in pregnant women and newborns: a 2-year study at Perugia General Hospital.

Sensini A, Tissi L, Verducci N, Orofino M, von Hunolstein C, Brunelli B, MalĂ  GL, Perocchi F, Brunelli R, Lauro V, Ferrarese R, Gilardi G.

Clin Microbiol Infect. 1997 Jun;3(3):324-328.

23.

Group B streptococci. Role of capsular polysaccharide on virulence and induction of septic arthritis.

Tissi L, von Hunolstein C, Parisi L, Bistoni F, Orefici G.

Adv Exp Med Biol. 1997;418:817-8. No abstract available.

PMID:
9331777
24.

Protective activity of a murine monoclonal antibody against acute and chronic experimental infection with type IV group B streptococcus.

Ricci ML, von Hunolstein C, Gomez MJ, Parisi L, Tissi L, Orefici G.

J Med Microbiol. 1996 Jun;44(6):475-81.

PMID:
8636965
25.
26.

Antibody-independent protection in mice against type Ia group B streptococcus lethal infection.

Scaringi L, Tissi L, Cornacchione P, Rosati E, Campanelli C, von Hunolstein C, Orefici G, Rossi R, Marconi P.

FEMS Immunol Med Microbiol. 1994 Aug;9(2):151-62.

PMID:
7804166
27.

Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis.

Tissi L, Marconi P, Mosci P, Merletti L, Cornacchione P, Rosati E, Recchia S, von Hunolstein C, Orefici G.

Infect Immun. 1990 Sep;58(9):3093-100.

28.

A murine model of systemic infection with serotype IV group B streptococcus.

Tissi L, Mosci P, Cornacchione P, Von Hunolstein C, Recchia S, Orefici G, Alberti P, Bistoni F, Marconi P.

J Chemother. 1989 Jul;1(4 Suppl):21-3. No abstract available.

PMID:
16312288
29.
30.

Induction of natural killer cell activity by inactivated Candida albicans in mice.

Marconi P, Scaringi L, Tissi L, Boccanera M, Bistoni F, Bonmassar E, Cassone A.

Infect Immun. 1985 Oct;50(1):297-303.

31.

[Immunostimulation with inactivated Candida albicans and chemotherapy in murine lymphoma].

Tissi L, Scaringi L, Cassone A, D'Errico P, Marconi P.

G Ital Chemioter. 1984 Jan-Aug;31(1-2):91-100. Italian. No abstract available.

PMID:
6381211
32.

[Immune response to a histocompatible murine lymphoma. Synergism with chemotherapy].

Scaringi L, Tissi L, Cassone A, Boccanera M, Marconi P.

G Ital Chemioter. 1984 Jan-Aug;31(1-2):81-90. Italian. No abstract available.

PMID:
6381210
33.

Combined effects of chemotherapy and host antitumor response in a murine histocompatible lymphoma model.

Marconi P, Scaringi L, Tissi L, Puccetti P, Cassone A.

Int J Immunopharmacol. 1984;6(3):217-22.

PMID:
6378809
34.

Relationships among tumor load, route of tumor inoculation, and response to immunochemotherapy in a murine lymphoma model.

Marconi P, Cassone A, Baccarini M, Tissi L, Garaci E, Bonmassar E, Frati L, Bistoni F.

J Natl Cancer Inst. 1983 Aug;71(2):299-307.

PMID:
6348362
35.

Immunopotentiation of anticancer chemotherapy by Candida albicans, other yeasts and insoluble glucan in an experimental lymphoma model.

Cassone A, Bistoni F, Cenci E, Pesce CD, Tissi L, Marconi P.

Sabouraudia. 1982 Jun;20(2):115-25.

PMID:
7051368
36.

Cellular mechanisms underlying the adjuvant activity of Candida albicans in a mouse lymphoma model.

Marconi P, Cassone A, Tissi L, Baccarini M, Puccetti P, Garaci E, Bonmassar E, Bistoni F.

Int J Cancer. 1982 Apr 15;29(4):483-8.

PMID:
7044994
37.

[Further study of immunopotentiation in experimental antiblastic therapy by inactivated yeasts and glucan].

Delfina Pesce C, Boccanera M, Marconi P, Bistoni F, Cenci E, Tissi L, Cassone A.

Ann Ist Super Sanita. 1982;18(3):509-12. Italian. No abstract available.

PMID:
7187836
38.

Protection test and early antibody response to tetanus immunization.

Marconi P, Bistoni F, Bastianini L, Tissi L, Sbaraglia G, Pitzurra M.

Boll Ist Sieroter Milan. 1980 Sep 30;59(4):374-9.

PMID:
7470279
39.

[Technic for studying antitetanus immunity].

Marconi P, Bistoni F, Tissi L, Mosci L, Cenci E, Pitzurra M, Lusian F.

Boll Ist Sieroter Milan. 1979 May 31;58(2):133-40. Italian.

PMID:
400102
40.

Haemagglutination antibody titre levels which give certain protection against tetanus toxin.

Bistoni F, Marconi P, Tissi L, Bastianini L, Pitzurra M.

Boll Ist Sieroter Milan. 1978 Nov 30;57(5):590-5.

PMID:
755487
41.

The state of antitetanus protection in the commune of Perugia.

Bistoni F, Marconi P, Bastianini L, Tissi L, Pitzurra M, Greco M.

Boll Ist Sieroter Milan. 1978 Nov 30;57(5):583-9.

PMID:
755486
42.

[Antibody response to tetanus and diphtheria toxoids in adult patients with solid neoplasms].

Marconi P, Bistoni F, Mosci L, Tissi L, Vecchiarelli A, Di Leo S, Dominici C, Pitzurra M.

Boll Soc Ital Biol Sper. 1978 Nov 30;54(22):2264-70. Italian. No abstract available.

PMID:
754725
43.

Anti-Candida albicans precipitating antibodies in the sera of surgery patients.

Marconi P, Bistoni F, Mosci L, Vecchiarelli A, Tissi L, Pitzurra A.

Boll Ist Sieroter Milan. 1977 Sep;56(4):321-7.

PMID:
334194

Supplemental Content

Support Center